Company Listing
Xenogen

Xenogen developed proprietary technologies, products and services to enable real-time in vivo monitoring for the identification of drug leads for clinical development. The company went public in July 2004 and was acquired for $80 million by Caliper Life Sciences in February 2006.

BACK
Location
Alameda, California

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

Xenogen developed proprietary technologies, products and services to enable real-time in vivo monitoring for the identification of drug leads for clinical development. The company went public in July 2004 and was acquired for $80 million by Caliper Life Sciences in February 2006.

Location
Alameda, California
BACK
 
Copyright Abingworth 2017